Search Results (461)

Background: Metal-based anticancer drugs, particularly platinum and gold complexes, play a central role in chemotherapy but are often limited by systemic toxicity, resistance, and suboptimal selectivity. Peptide conjugation has emerged as a versatile strategy to modulate the pharmacokinetic and biological properties of metal complexes, enabling targeted delivery, improved uptake, and controlled activation. This review aims to critically analyze platinum- and gold-peptide bioconjugates in cancer therapy, focusing on directly reactive metal complexes and redox-activated prodrug systems. Methods: Relevant literature from the past two decades was surveyed across major scientific databases, focusing on the design, conjugation strategies, biological activity, and mechanisms of action of Pt- and Au-peptide bioconjugates. Results: Reviewed studies reveal distinct behavior for platinum- and gold-based systems. Pt(II)-peptide conjugates primarily retain DNA-reactive interaction, with peptides mainly enhancing cellular uptake, selective targeting and solubility, although improved cytotoxicity is not consistently achieved. In contrast, Pt(IV)-peptide conjugates function as prodrugs, where axial peptide functionalization allows greater structural versatility and sometimes improved selectivity, with therapeutic efficacy strongly depending on intracellular reduction kinetics. Au(I)-peptide conjugates act as directly reactive species targeting thiol- and selenol-containing proteins, whereas Au(III) bioconjugates often behave as redox-activated prodrugs, with peptide conjugation influencing stability and cellular fate. Conclusions: Overall, peptide conjugation represents a powerful but non-trivial approach for optimizing metal-based anticancer agents. The success of metal-peptide bioconjugates critically depends on balancing peptide-mediated delivery with the intrinsic reactivity and activation pathways of the metal center. A function-guided design of bioconjugates is essential to achieve genuine selectivity and therapeutic benefit. Full article

We developed a smartphone-assisted digital image-based optical biosensor array using a planar glass slide with sensor spots in a 2 × 5 array format for point-of-care multiplex detection of biomarkers. The detection is based on the integration of the capture antibody (Ab^C)-functionalized sensor array with a detection antibody-conjugated gold nanoparticle bioconjugate (AuNP@Ab^D) in the presence of interleukin-8 (IL8) to form a sandwich-type AuNP@Ab^D–IL8–Ab^C nanocomplex on the sensing spot surface. Thus, the colorimetric detection method can be applied to the quantitative analysis of IL8, a clinically relevant pro-inflammatory and pro-angiogenic biomarker. The sensing strategy utilizes digital image-based analysis via ImageJ software (V 1.54 g; Java 1.8.0_345 [64 − bit], Windows 8) to quantify the colorimetric signals generated by the light absorbance of surface-bound gold nanoparticles in response to an IL8 droplet sample of merely 8 μL on the planar glass surface, achieving a low detection limit of 0.23 pg/mL (27 fM) and good reproducibility with a coefficient of variation of 0.95%. Validation using IL8-spiked serum at concentrations of 1 × 10⁻⁹ M and 1 × 10⁻¹⁰ M showed minimal matrix effects with a detection accuracy of 99.5% and 106.1%, respectively. Hence, this low-cost portable digital image-based plasmonic nanoparticle-linked immunosorbent assay serves as an alternative to traditional enzyme-linked immunosorbent assays. Full article

The interplay of the carbohydrate polysialic acid (polySia) with its interaction partners plays an important role in several physiological systems of vertebrates. The objective of this study was to develop a flexible analytical system for visualizing interaction partners of polySia using blotting and fluorescence cell staining strategies. We selected a streptavidin–biotin system due to the wide range of commercially available tools for this analytical application. After chemical polysialylation of streptavidin, the resulting bioconjugate was used to target polySia interaction partners after they had been separated via native agarose gel electrophoresis and transferred to a PVDF membrane. Furthermore, neutrophil extracellular traps (NETs) were employed to visualize polySia interaction partners within a cellular system using fluorescence-labeled biotin. The obtained results demonstrate that polysialylated streptavidin is a flexible bioconjugate that can be applied to investigate polySia interaction partners using various blotting and fluorescence imaging techniques. Full article

We present an optimized method for producing semiconducting polymer dots using a water–ethanol mixed antisolvent during nanoprecipitation. Compared to conventional Pdots made with pure water as the antisolvent, these newly produced Pdots exhibit simultaneously enhanced fluorescence efficiency and stability of particle size and emission spectra. These findings should be mainly attributed to an improved core–shell Pdots nanostructure formed by a sequential nanoprecipitation process. It offers Pdots a purer, more compact, and hydrophobic inner core, coated with a greater number of hydrophilic polyethylene glycol shells. This viewpoint is further reinforced by Förster energy-transfer efficiency in a fluorescence donor-acceptor Pdots system. The novelly prepared Pdots can better encapsulate small-molecular cargoes and more efficiently bioconjugate to targets. Consequently, it demonstrates improved specific immunofluorescence staining of microtubule structures in living cells. Full article

Background: Peptides are promising tools in medicine for viral, bacterial, and parasitic infections. MAP1 and MAP2 are peptides with antimicrobial activity. Aiming to increase selectivity, enhance antimicrobial activity, and reduce its cytotoxicity, two bioconjugates (GVL1-MAP2 and GVL1-MAP1) with the guanidine derivative group in the N-terminus position were synthesized. Methods: The peptides and bioconjugates were synthesized by SPPS. The biological activity and inhibition of the CPB enzyme were evaluated. Results: Antileishmanial activity was evaluated, and the bioconjugates exhibited higher activity in both the promastigote and amastigote forms than isolated GVL1 and peptides alone. Discussion: GVL1-MAP2 bioconjugate demonstrated not only the greatest activity against L. amazonensis in the promastigote (IC₅₀ = 3.2 μM) and amastigote (IC₅₀ = 0.6 μM) forms but also prevented the parasite from infecting new host cells, reducing the infection rate by 3-fold compared to the untreated control. Similar results were obtained in L. infantum, with IC₅₀ = 2.5 and 1.0 μM for promastigote and amastigote forms, respectively. In active serum, GVL1-MAP2 continued to show high activity. GVL1-MAP2 also showed bactericidal activity against most strains tested. The bioconjugate GVL1-MAP2 showed lower cytotoxicity than GVL1-MAP1 and amphotericin B in macrophages. Permeabilization studies and enzyme inhibition revealed that the peptide acts via at least two distinct mechanisms, with the primary mechanism targeting the membrane and inner targets as an inhibitor of the CPB enzyme. Conclusions: These data demonstrated that the synthesis of bioconjugates can be a tool for the development of bactericidal and antileishmanial compounds with improved potency and selectivity. Full article

Hierarchical functionalisation of the UiO-66(Zr)-NH₂ metal–organic framework with cysteine, poly(ethylene glycol) (PEG), and the SARS-CoV-2 spike receptor-binding domain (RBD) was developed to enable receptor-specific interaction with the angiotensin-converting enzyme 2 receptor (ACE2) in model cells. Post-synthetic modification using cysteine and heterobifunctional PEG linkers allowed controlled bioconjugation of SpyTag-labelled RBD via SpyTag/SpyCatcher chemistry, while preserving the crystallinity, microporosity, and intrinsic optical properties of the UiO-66(Zr)-NH₂ framework. Comprehensive physicochemical characterisation confirmed successful surface functionalisation, tunable aggregation behaviour, and retention of multimodal optical characteristics. Cellular studies in HEK293T and HeLa cells overexpressing EGFP-tagged ACE2 demonstrated enhanced and selective association and uptake of RBD-functionalised nanoparticles compared with non-targeted analogues. Multimodal fluorescence imaging, fluorescence lifetime imaging microscopy, flow-cytometry, and electron microscopy indicated ACE2-dependent endocytic internalisation, with predominant localisation in endosomal and autophagosomal compartments, while both amine- and cysteine-modified formulations exhibited good biocompatibility. Overall, this study establishes a virus-mimetic, ACE2-targeted UiO-66(Zr)-based nanosystem as a proof-of-concept biointerface platform for receptor-specific cellular delivery and imaging, providing a foundation for future MOF-based nanocarriers exploiting ligand–receptor interactions. Full article

Background: Zirconium-89 (⁸⁹Zr) is a key PET radionuclide and the limited in vivo stability of its clinically used ⁸⁹Zr-DFO complexes has driven the pursuit of improved chelator architectures. Among these, DFO* has attracted particular attention due to its exceptional complex stability with ⁸⁹Zr⁴⁺ and favorable pharmacokinetics of the corresponding bioconjugates in vivo. Despite these advantages, DFO*’s broader application has been hampered by significant synthetic challenges, primarily arising from its pronounced acid sensitivity. Methods: Here, we present a systematic investigation of the acid lability of DFO and DFO*-derived systems, revealing substantial degradation under acidic conditions being commonly applied during preparation and purification. These findings highlight critical limitations of conventional synthetic and purification protocols. To address this, we developed two complementary synthetic routes that consistently avoid fragmentation-inducing conditions. Results: THP/Boc- and TBDPS/Fmoc-based routes provide robust five- and six-step syntheses of DFO*, affording overall yields of 11% and 13%/6.1% and high purity (≥98%) without detectable degradation. Conclusions: By systematically investigating the acid sensitivity of DFO/DFO*-based chelators and providing practical synthetic solutions, this work enables reliable access to DFO* and advances its application in ⁸⁹Zr radiopharmaceutical development. Full article

Fluorine-18 is often considered an ideal positron emitter owing to its excellent chemical, physiological, and nuclear properties. Consequently, the development of rapid, simple, and reliable ¹⁸F-labeling strategies remains critically important for synthesizing new radiopharmaceuticals for PET molecular imaging. A common approach involves the synthesis of ¹⁸F-labeled prosthetic groups that subsequently undergo bioconjugation with peptides or other biomolecules to generate ¹⁸F-labeled imaging probes. However, conventional synthetic methods for these prosthetic groups are often lengthy, require large quantities of precursor and solvent, and typically rely on elevated reaction temperatures. Herein, we report a droplet-based microscale synthetic methodology for the preparation of the [¹⁸F]FVSB prosthetic group that minimizes precursor and solvent usage, proceeds rapidly, and operates at relatively low temperatures. Conditions were optimized using a platform for performing droplet reactions in parallel, enabling high-throughput study of multiple reaction parameters within a short period of time. Additionally, we introduce a simple micro-cartridge purification technique that affords purified [¹⁸F]FVSB in small volumes. Furthermore, we describe an efficient bioconjugation that requires substantially lower reagent amounts than the previously reported macroscale method. The microscale process we report could facilitate wider use of this ¹⁸F-labeling strategy and can be extended to label other thiol-bearing peptides or biomolecules. Full article

The emerging threat of antibiotic-resistant pathogens and the limitations that conventional cancer chemotherapies display have created an urgent need for the development of innovative therapeutic strategies. Combining the pleiotropic biological roles of antimicrobial peptides (AMPs) and nanomaterials through their conjugation presents a promising possibility of targeting both microbial membranes and malignant cells. In the present study, we engineered a novel bioactive material by immobilizing the insect-derived AMP Papiliocin onto multi-walled—decorated with polyethylene–glycol—carbon nanotubes (PEG-MWCNTs) to prevent proteolytic degradation of the peptide and enhance its cellular delivery. Recombinant Papiliocin was cloned, heterologously expressed, purified and conjugated onto the PEG-MWCNT carrier. Successful expression and conjugation were validated via immunoblotting and Fourier transform infrared (FT-IR) spectroscopy, respectively. Further physicochemical characterization of the bionanocomposites was conducted using Dynamic Light Scattering (DLS) and Zeta potential measurements. Biologically, the biofunctionalized material exhibited potent, broad-spectrum antimicrobial activity both on Staphylococcus aureus and Escherichia coli, inhibiting almost 90% of the latter’s growth, highlighting the bioconjugate’s specific interactions with the Gram-negative pathogens’ membranes. Furthermore, it significantly reduced biofilm formation in Candida albicans, as indicated by the TCP assay. In parallel with its antimicrobial effects, CNTs-PEG–Papiliocin significantly reduced cancer cell viability and induced apoptosis via the extrinsic apoptosis pathway in HeLa cells, a response assisted by efficient intracellular delivery. Notably, cytotoxicity assays demonstrated lesser cytotoxic effect against non-tumorigenic HaCaT cells relative to the cancerous cell line. Collectively, these findings indicate the Papiliocin–biofunctionalized CNTs as a versatile, dual-action therapeutic agent with potential for antimicrobial activity and anticancer mode of action. Full article

The synthesis of three novel, valuable bioconjugates obtained by coupling cholesterol bromoacetate with pyridine derivatives via an SN2 reaction was successfully carried out. Each of the products was fully characterized by magnetic nuclear resonance (¹H, ¹³C, APT, ¹H−¹H COSY, ¹H–¹³C HMBC, ¹H–¹³C HSQC), infrared spectroscopy (IR), and high-resolution mass spectrometry (HRMS). Full article

Gum arabic (GA) is a widely used natural hydrocolloid in food processing because its protein–polysaccharide architecture combines high water solubility, low bulk viscosity, and useful interfacial activity. These attributes make GA valuable as an emulsifier, encapsulating agent, and film-forming material, but native GA is constrained by source-dependent heterogeneity, limited antioxidant functionality, relatively high dosage requirements in some emulsions, and modest barrier and mechanical performance in dried matrices. This review synthesizes recent advances in chemical functionalization, enzymatic and oxidative grafting, physical fractionation and complexation, and Maillard-type bioconjugation as routes to tailor GA for food engineering applications. Emphasis is placed on process-relevant structure–property relationships, including dynamic adsorption, interfacial rheology, emulsifying and encapsulation efficiency, bulk rheology, powder glass transition and hygroscopicity, film barrier behavior, and release kinetics. Across beverage emulsions, spray-dried powders, coacervates, coatings, and delivery systems, the evidence shows that modification must be selected according to the dominant process bottleneck, such as adsorption kinetics, oxidative stability, drying behavior, or humidity-sensitive matrix mobility. This review also identifies priorities for translation, including model-ready measurements, the management of raw-material variability, scale-up-aware processing, and sustainability and regulatory practicality. Overall, modified GA emerges as a versatile platform for designing more robust, application-specific food colloids, encapsulates, and functional coatings. Full article

The development of effective and trackable drug delivery systems remains a major challenge in anticancer therapy. In this study, we designed novel polysaccharide-based theranostic carriers using a yeast-shell (YC) framework, providing a biocompatible platform for intracellular drug delivery. For the first time, a chitosan–genipin bioconjugate was synthesized via a solvent-free, green mechanochemical method and applied as an outer coating to microcarriers encapsulating the anticancer drug 5-fluorouracil (5-FU) and the fluorescent dye phenosafranin. The resulting system enabled simultaneous fluorescence tracking and the controlled release of the chemotherapeutic agent. In vitro evaluation using the MDA-MB-231 triple-negative breast cancer cell line demonstrated that 5-FU retained its antiproliferative activity, while the carriers facilitate sustained intracellular delivery. These findings highlight the potential of YC-based polysaccharide carriers, surface- modified with chitosan–genipin to enhance hydrophilicity, as a versatile platform for anticancer therapy, combining biocompatibility, traceability, and controlled drug release. Full article

Ruthenocene (Rc) and its derivatives form a structurally versatile class of metallocenes with unique and multifunctional applicability. This review presents a detailed analysis of Rc chemistry including the structural comparison with ferrocene, its redox behavior, and substituent effects. We also discuss its applications in sensing, energy storage, photochemistry, and biomedicine. Rc exhibits unique conformational and adaptive electronic properties based on one and two-electron oxidation processes. Electrochemical investigations of Rc to date indicate that its redox behavior is strongly dependent on the electrolyte system, exhibiting quasi-Nernstian characteristics, the formation of stabilized dimeric species [Rc₂]²⁺, and interconversion among Ru(II), Ru(III), and Ru(IV) oxidation states. Rc-based systems exhibit superior performance as redox mediators and labels in electrochemical sensing systems in terms of electron-transfer kinetics, signal amplification, and surface immobilization. In the field of energy storage, Rc decreases the charging overpotential and increases the cycle life of Li-O₂ batteries. Rc further acts as a photoinitiator via charge-transfer-to-solvent and efficient photoinduced electron transfer in metalloporphyrin and fullerene dyads. In biomedical research, Rc derivatives as well as bioconjugates possess promising anticancer activities, displaying reactive oxygen species generation, topoisomerase inhibition, thioredoxin reductase inhibition, receptor-mediated uptake, and target peptide conjugation. Given its flexible ligand design, electrolyte driven redox behaviors, and antiproliferative properties, Rc exhibits a very adaptive molecular scaffold for next generation electrochemical technologies as well as metallodrug design. Full article

Klebsiella pneumoniae poses a severe global health threat due to its extensive antibiotic resistance. However, to date, no vaccine against this pathogen has been approved for clinical use worldwide. Although self-assembling nanocarriers present distinct advantages for vaccine design, their ability to effectively load polysaccharide antigens and further elicit mucosal immunity remains unclear. Here, we developed a modular, self-assembling nanovaccine (CNP-OPS_KpO1) against K. pneumoniae by loading of K. pneumoniae O1 polysaccharide antigen onto a cholera toxin B subunit (CTB)-based nanoparticle (CNP). After determining the safety of the vaccine via intranasal immunization, we further evaluated its immune efficacy. CNP-OPS_KpO1 elicited stronger systemic IgG and mucosal sIgA responses than non-nanoparticulate controls. In a non-lethal pulmonary infection model, CNP-OPS_KpO1 vaccination reduced lung bacterial burden by over 5 logs compared to controls, achieving near-complete bacterial clearance. Histopathological analysis further confirmed minimal lung damage in vaccinated animals. In addition, in a lethal pulmonary challenge model, it conferred 90% survival, whereas all mice in the antigen-alone control group died within 4 days. Our work not only provides a safe, effective, and adjuvant-free candidate vaccine against K. pneumoniae but also advances a versatile platform for developing broad-spectrum mucosal vaccines against other pathogens. Full article

Electrochemical biosensors integrated into wearable devices have revolutionized the technology in terms of health monitoring and diagnostic systems. However, when it comes to moving the devices from the laboratory to real-world environments, a critical problem emerges with the interface. The problem, in essence, is that biorecognition elements tend to lose their activity, delaminate, and drift when exposed to various environmental stresses. The traditional methods for the immobilization of the biorecognition elements result in receptors with random orientations, hydrolytically unstable bonds, and batch-to-batch variability, regardless of the method, including physisorption or non-selective covalent attachment, like using EDC/NHS. This review is organized around a comparative question: which limitations of classical immobilization strategies (physisorption, self-assembled monolayers used as passive anchoring platforms, and EDC/NHS coupling) can be resolved by click chemistry, which can be resolved by mechanistic features? Accordingly, CuAAC, SPAAC, IEDDA, and thiol-ene/yne photoclick reactions are discussed, not as an isolated catalog of ligations, but as complementary solutions to specific interfacial failure modes, including random bioreceptor orientation, hydrolytically vulnerable attachment, poor batch reproducibility, catalyst sensitivity, and the difficulty of functionalizing soft polymeric or textile substrates. In this framework, click chemistry is treated as a deterministic interface-engineering strategy that enables defined covalent fixation, programmable probe density, and improved mechanical and electrochemical robustness under wearable operating conditions. Full article